Objectives The aim of the study was to analyse the prevalence of integrase resistance
mutations in integrase strand transfer inhibitor (INSTI)‐experienced HIV‐1‐infected patients …

Integrase strand transfer inhibitor (InSTI) resistance rates are low. However, genotypic
resistance test (GRT) is not routinely performed in many centers. The aim of this study is to …

Objectives To describe integrase strand transfer inhibitor (INSTI) resistance profiles and
factors associated with resistance in antiretroviral-naive and-experienced patients failing an …

Objectives This study evaluated the emergence of mutations associated with integrase
strand transfer inhibitors (INSTI) resistance (INSTI-RMs) and the integrase evolution in …

Objectives The objective of this study was to define the natural genotypic variation of the HIV-
1 integrase gene across Europe for epidemiological surveillance of integrase strand-transfer …

Background US guidelines recommend genotyping for persons newly diagnosed with HIV
infection to identify transmitted drug resistance mutations associated with decreased …

Objectives The aim of this study was to characterize the prevalence and patterns of
genotypic integrase inhibitor (INI) resistance in relation to HIV-1 clade. Methods The cohort …

The prevalence of integrase strand transfer inhibitor (INSTI)–transmitted drug resistance
(TDR) may increase with the increasing use of INSTIs. We analyzed the prevalence of INSTI …

Background and Objective: Integrase strand transfer inhibitors (INSTIs) are currently the
standard of practice for first-line HIV therapy for most patients. We evaluated the mutations …

Background Transmission of resistance mutations to integrase strand transfer inhibitors
(INSTIs) in HIV-infected patients may compromise the efficacy of first-line antiretroviral …